Matches in SemOpenAlex for { <https://semopenalex.org/work/W2917195146> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2917195146 endingPage "63" @default.
- W2917195146 startingPage "56" @default.
- W2917195146 abstract "Omadacycline is an aminomethylcycline antibacterial (oral and intravenous once-daily formulation) that recently (October 2018) received United States Food and Drug Administration (FDA) approval for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and community-acquired bacterial pneumonia (CABP) against selected organism groups. This study tested omadacycline and comparators against 14 000 non-duplicate bacterial isolates that were prospectively collected during 2017 from medical centres in Europe (EUR; 7000 isolates) and the United States (USA; 7000 isolates).Omadacycline was tested by broth microdilution following Clinical and Laboratory Standards Institute M07-A11 (2018) methods.A total of 98.7% ofStaphylococcus aureus isolates were susceptible to omadacycline (MIC50/90, 0.12/0.25mg/L; ABSSSI breakpoints) including 96.5% of methicillin-resistant Staphylococcus aureus (MRSA), 99.8% of methicillin-susceptible Staphylococcus aureus, and 93.9% of tetracycline-resistant strains. Omadacycline activity was similar for Streptococcus pneumoniae (MIC50/90 0.06/0.12mg/L; 98.6% susceptible [CABP breakpoints]), Streptococcus anginosus group (MIC50/90 0.06/0.06mg/L; 100.0% susceptible [ABSSSI breakpoints]), and Streptococcus pyogenes (MIC50/90 0.06/0.12mg/L; 97.7% susceptible [ABSSSI breakpoints]). Omadacycline demonstrated activity against Enterobacter cloacae species complex isolates (MIC50/90, 2/4mg/L; 91.2% susceptible [ABSSSI breakpoints]), Klebsiella pneumoniae (MIC50/90, 2/8mg/L; 87.5% susceptible [CABP and ABSSSI breakpoints]), and inhibited 99.1% of Escherichia coli (MIC50/90, 0.5/2mg/L) isolates at ≤ 4mg/L. Omadacycline was active against Haemophilus influenzae (MIC50/90, 0.5/1mg/L; 99.8% susceptible [CABP breakpoints]), including all β-lactamase positive isolates, and inhibited 100.0% of Moraxella catarrhalis isolates at ≤ 0.25mg/L.The potent activity of omadacycline against Gram-positive and Gram-negative bacteria indicates that omadacycline merits further study in serious infections in which multidrug resistance and mixed Gram-positive and Gram-negative infections may be of concern." @default.
- W2917195146 created "2019-03-02" @default.
- W2917195146 creator A5006715126 @default.
- W2917195146 creator A5028081249 @default.
- W2917195146 creator A5028735988 @default.
- W2917195146 creator A5063491070 @default.
- W2917195146 date "2019-12-01" @default.
- W2917195146 modified "2023-10-14" @default.
- W2917195146 title "Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017" @default.
- W2917195146 cites W2002222742 @default.
- W2917195146 cites W2012251902 @default.
- W2917195146 cites W2119629693 @default.
- W2917195146 cites W2136678955 @default.
- W2917195146 cites W2162987252 @default.
- W2917195146 cites W2168841364 @default.
- W2917195146 cites W2170502369 @default.
- W2917195146 cites W2507274521 @default.
- W2917195146 cites W2590368139 @default.
- W2917195146 doi "https://doi.org/10.1016/j.jgar.2019.02.017" @default.
- W2917195146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30825698" @default.
- W2917195146 hasPublicationYear "2019" @default.
- W2917195146 type Work @default.
- W2917195146 sameAs 2917195146 @default.
- W2917195146 citedByCount "30" @default.
- W2917195146 countsByYear W29171951462019 @default.
- W2917195146 countsByYear W29171951462020 @default.
- W2917195146 countsByYear W29171951462021 @default.
- W2917195146 countsByYear W29171951462022 @default.
- W2917195146 countsByYear W29171951462023 @default.
- W2917195146 crossrefType "journal-article" @default.
- W2917195146 hasAuthorship W2917195146A5006715126 @default.
- W2917195146 hasAuthorship W2917195146A5028081249 @default.
- W2917195146 hasAuthorship W2917195146A5028735988 @default.
- W2917195146 hasAuthorship W2917195146A5063491070 @default.
- W2917195146 hasConcept C104317684 @default.
- W2917195146 hasConcept C176947019 @default.
- W2917195146 hasConcept C185592680 @default.
- W2917195146 hasConcept C2776933286 @default.
- W2917195146 hasConcept C2777058267 @default.
- W2917195146 hasConcept C2777402170 @default.
- W2917195146 hasConcept C2778276568 @default.
- W2917195146 hasConcept C2779489039 @default.
- W2917195146 hasConcept C2780950330 @default.
- W2917195146 hasConcept C2781253189 @default.
- W2917195146 hasConcept C2910829522 @default.
- W2917195146 hasConcept C4937899 @default.
- W2917195146 hasConcept C501593827 @default.
- W2917195146 hasConcept C523546767 @default.
- W2917195146 hasConcept C54355233 @default.
- W2917195146 hasConcept C547475151 @default.
- W2917195146 hasConcept C55493867 @default.
- W2917195146 hasConcept C71924100 @default.
- W2917195146 hasConcept C86803240 @default.
- W2917195146 hasConcept C89423630 @default.
- W2917195146 hasConceptScore W2917195146C104317684 @default.
- W2917195146 hasConceptScore W2917195146C176947019 @default.
- W2917195146 hasConceptScore W2917195146C185592680 @default.
- W2917195146 hasConceptScore W2917195146C2776933286 @default.
- W2917195146 hasConceptScore W2917195146C2777058267 @default.
- W2917195146 hasConceptScore W2917195146C2777402170 @default.
- W2917195146 hasConceptScore W2917195146C2778276568 @default.
- W2917195146 hasConceptScore W2917195146C2779489039 @default.
- W2917195146 hasConceptScore W2917195146C2780950330 @default.
- W2917195146 hasConceptScore W2917195146C2781253189 @default.
- W2917195146 hasConceptScore W2917195146C2910829522 @default.
- W2917195146 hasConceptScore W2917195146C4937899 @default.
- W2917195146 hasConceptScore W2917195146C501593827 @default.
- W2917195146 hasConceptScore W2917195146C523546767 @default.
- W2917195146 hasConceptScore W2917195146C54355233 @default.
- W2917195146 hasConceptScore W2917195146C547475151 @default.
- W2917195146 hasConceptScore W2917195146C55493867 @default.
- W2917195146 hasConceptScore W2917195146C71924100 @default.
- W2917195146 hasConceptScore W2917195146C86803240 @default.
- W2917195146 hasConceptScore W2917195146C89423630 @default.
- W2917195146 hasLocation W29171951461 @default.
- W2917195146 hasLocation W29171951462 @default.
- W2917195146 hasOpenAccess W2917195146 @default.
- W2917195146 hasPrimaryLocation W29171951461 @default.
- W2917195146 hasRelatedWork W2017369909 @default.
- W2917195146 hasRelatedWork W2031470162 @default.
- W2917195146 hasRelatedWork W2113898784 @default.
- W2917195146 hasRelatedWork W2164435406 @default.
- W2917195146 hasRelatedWork W2753184995 @default.
- W2917195146 hasRelatedWork W2954159082 @default.
- W2917195146 hasRelatedWork W2968743820 @default.
- W2917195146 hasRelatedWork W2978793169 @default.
- W2917195146 hasRelatedWork W2494133291 @default.
- W2917195146 hasRelatedWork W2894777053 @default.
- W2917195146 hasVolume "19" @default.
- W2917195146 isParatext "false" @default.
- W2917195146 isRetracted "false" @default.
- W2917195146 magId "2917195146" @default.
- W2917195146 workType "article" @default.